VANCOR Drug Patent Profile
✉ Email this page to a colleague
When do Vancor patents expire, and when can generic versions of Vancor launch?
Vancor is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in VANCOR is vancomycin hydrochloride. There are twenty-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vancor
A generic version of VANCOR was approved as vancomycin hydrochloride by FRESENIUS KABI USA on March 17th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VANCOR?
- What are the global sales for VANCOR?
- What is Average Wholesale Price for VANCOR?
Summary for VANCOR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 37 |
| DailyMed Link: | VANCOR at DailyMed |
US Patents and Regulatory Information for VANCOR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | VANCOR | vancomycin hydrochloride | INJECTABLE;INJECTION | 062956-002 | Aug 1, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmacia And Upjohn | VANCOR | vancomycin hydrochloride | INJECTABLE;INJECTION | 062956-001 | Aug 1, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
